drugset / Trial / NCT00880581

A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas

NCT00880581

Phase 2 Completed 30 enrolled Ronald Levy Pfizer · collab
NaSingle-groupOpen-labelTreatment

Summary

To assess the feasibility of using intra-tumoral PF-3512676 in combination with local radiation as a therapy for lowgrade b-cell lymphoma.

Timeline

Start
2009-01
Primary completion
2011-09
Completion
2015-01

Drugs

EvaluationDrugModalityDoseRoute
Subject agatolimod Oligonucleotide (other) 18 mg Other